Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.8%

61 terminated/withdrawn out of 515 trials

Success Rate

81.5%

-5.0% vs industry average

Late-Stage Pipeline

13%

68 trials in Phase 3/4

Results Transparency

41%

109 of 268 completed trials have results

Key Signals

77 recruiting109 with results42 terminated19 withdrawn

Enrollment Performance

Analytics

N/A

202(50.8%)

Phase 2

67(16.8%)

Phase 1

50(12.6%)

Phase 4

40(10.1%)

Phase 3

28(7.0%)

Early Phase 1

11(2.8%)

398Total

N/A(202)

Phase 2(67)

Phase 1(50)

Phase 4(40)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (515)

Showing 20 of 515 trials

NCT06414590Phase 2Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

Role: lead

NCT07646522Phase 2Not Yet Recruiting

Telerehabilitation and Biomarkers of Recovery After Stroke in Brazil

Role: collaborator

NCT07145801Phase 2Recruiting

Y-90 Treatment Response Using Transarterial Radioembolization

Role: lead

NCT07387354Phase 1Not Yet Recruiting

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

Role: lead

NCT05929664Phase 2Suspended

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Role: lead

NCT07362433Phase 4Recruiting

Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship

Role: collaborator

NCT04097158Recruiting

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Role: collaborator

NCT06024772Phase 3Not Yet Recruiting

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Role: lead

NCT07620535Not Yet Recruiting

Decision Counseling and Follow-up for Shield+ Patients

Role: collaborator

NCT03245411Not ApplicableRecruiting

Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Role: lead

NCT06036446Not ApplicableRecruiting

LATe Cerclage in High-risk Pregnancies (LATCH)

Role: lead

NCT06089954Not ApplicableActive Not Recruiting

Penn Medicine Biobank Return of Results Program

Role: collaborator

NCT05966038Recruiting

ALS/MND Natural History Study Data Repository

Role: collaborator

NCT07599865Phase 2Not Yet Recruiting

Periprosthetic Joint Infection Bubble Study

Role: lead

NCT05564650Phase 1Completed

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Role: lead

NCT02943642Phase 2Withdrawn

Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides

Role: collaborator

NCT05627219Recruiting

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Role: lead

NCT07414550Not ApplicableRecruiting

Radiotherapy for Refractory Hidradenitis Suppurativa

Role: lead

NCT05804240Completed

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Role: lead

NCT04474548Not ApplicableTerminated

Postplacental LNG-IUD Ultrasound Use Study

Role: lead